Features of thyroid status in women under hyperplasia of the thyroid gland, combined with noncalculous cholecystitis
DOI:
https://doi.org/10.24144/2415-8127.2019.59.87-91Keywords:
noncalculous cholecystitis, thyroid gland hyperplasia, thyroid status, hypothyroidism.Abstract
It was conducted a comprehensive survey of 87 women aged 22-54 years who had chronic noncalculous cholecystitis as the main diagnosis, and hyperplasia of the thyroid gland was firstly established in the conditions of the resort Truskavets, and accordingly, these women did not use drugs for its treatment. It was found that in the presence of thyroid gland hyperplasia and noncalculous cholecystitis, thyroid status in women is characterized by hypofunction of the thyroid gland, and changes in it functioning occur by the type of hypothyroidism. The thyroid status of such patients, according to some features, corresponds to subclinical, in some cases – manifest primary hypothyroidism in addition with the syndrome of "low T3". The values of the parameters that characterize the hormonal status of the patients, in its pure form not meet any of these pathological conditions.
References
Adamova YaH, Chumachenko AN. Morfolohycheskye osobennosty razlychnoi patolohyy shchytovydnoi zhelezы u naselenyia, prozhyvaiushcheho v tekhnohenno-zahriaznennom rehyone. Arkhyv patolohyy. 2007;69(2)- 24-27. [In Russian].
Baskakov PN, Hlazkov YB. Korrektsyia dysmetabolycheskykh narushenyi u patsyentok s klymakterycheskym syndromom na fone zabolevanyi shchytovydnoi zhelezы y pecheny. Reproduktyvnoe zdorove zhenshchynы. 2005;1:42-43. [In Russian].
Braverman LY. Bolezny shchytovydnoi zhelezы. M.: Medytsyna. 2000. 256 c.
Borzyn VA, Herbylskyi LV, Kornylovskaia YN. Tyreohlobulyn. Problemы эndokrynolohyy. 1993;4:54-59. [In Russian].
Verbovoi AF. Syndrom hypotyreoza [Elektronnyi resurs]. Farmateka. 2015;10: http://www.medvestnik.ru/library/article/31601. [In Russian].
Vzaymosviaz mezhdu porazhenyiamy shchytovydnoi zhelezy y pecheny (obzor lyteraturы). – Rezhym dostupu: http://www.med-practic.com/rus/147/18796/Vzaymosviaz mezhdu porazhenyiamy shchytovydnoi zhelezы y pecheny/article.more.html. [In Russian].
Herasymov HA, Troshyna EA. Dyfferentsyalnaia dyahnostyka y vыbor metoda lechenyia pry uzlovom zobe. Problemы эndokrynolohyy. 1998;5:35-41. [In Russian].
Horiachkovskyi AM. Klynycheskaia byokhymyia. Odessa: Astroprynt. 1998. 608 s. [In Russian].
Zviahyntseva TD, Sharhorod YY. Khronycheskyi beskamennыi kholetsystyt: klynyka, dyahnostyka y lechenye. Skhidnoievropeiskyi zhurnal vnutrishnoi ta simeinoi medytsyny. 2015;2:13-19. [In Russian].
Ymmunolohycheskaia dyahnostyka v akusherstve y hynekolohyy. NPP «mTm». 26 s. [In Russian].
Proshchaev KY, Ylnytskyi AN, Kniazkyn YV, Kvetnoi YM. Molekuliarnaia neiroymmunoэndokrynolohyia y klynycheskaia patofyzyolohyia. SPb.: DEAN. 2006. 304 s. [In Russian].
Oleinyk VA. Hypotyreoz: patolohyia, o kotoroi vsehda nuzhno pomnyt. Ukrainskyi medychnyi visnyk. 2006;2:14-18. [In Russian].
Pavlov AV. Yspolzovanye mykroiadernoho testa dlia vыiavlenyia henotoksycheskykh povrezhdenyi shchytovydnoi zhelezы. Biulleten эksperymentalnoi byolohyy y medytsynы. 2006;141(1): 99-102. [In Russian].
Svyrydenko NIu, Kosianova NA. Hypotyreoz: dyahnostyka, pryntsypы zamestytelnoi terapyy. Russkyi medytsynskyi zhurnal. 2006;14(26): 1911-16. [In Russian].
Feisa SV. Patolohiia shchytopodibnoi zalozy ta nealkoholna zhyrova khvoroba pechinky. Ukraina. Zdorov’ia natsii. 2016;1–2: 198-202. [In Ukrainian].
Shakhtryn VV, Petrova HA, Chekyn SIu. Novыe podkhodы k kolychestvennoi otsenke metabolyzma tryiodtyronyna v orhanyzme. Problemы эndokrynolohyy. 2000;1: 34-37. [In Russian].
Kubarko AY, Yamasyta S.Shchytovydnaia zheleza. Fundamentalnыe aspektы. Mynsk-Nahasaky. 1998. 368 s. [In Russian].
Tytsa NU. Эntsyklopedyia klynycheskykh laboratornыkh testov. M.: Labynform. 1997. 942 s. [In Russian].
Anty R, Lemoine M. Liver fibrogenesis and metabolic factors. Clin. Res. Hepatol. Gastroenterol. 2011;35(1):10–20.
Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 2008;29:76– 131.
De Escobar HM. Autoimmune thyroid disease susceptibility Best Pract. Res. Clin. Endocrinal. 2004;19(2):311-15.
Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(2):287-93.
Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J. Intern. Med. 2006; 260(1):53–61.
Bavab RCM, Derone D, Castro AVB, et al. Low triiodthyronine (ТЗ) or reverse triodthyronine (rT3) syndrome modifies gene expression in rats with congestive heart failure. Endocr. Res. 2005;31(4):397-405.
Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction : a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J. Clin. Endocrinol. Metabol. 2005; 90(1):581-85.
Tu HM. Regional distribushion of type 2 thyroxin deiodinase messenger ribonuk- leic acid in rat hypothalamus and pituitari and its regilation by thyroid hormone. M. Endocrinology. 1997;8:3359-68.
